Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to APO Research, The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Includes
This report presents an overview of global market for Tuberculosis (TB) Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tuberculosis (TB) Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Tuberculosis (TB) Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tuberculosis (TB) Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis (TB) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tuberculosis (TB) Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
Tuberculosis (TB) Diagnostics segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tuberculosis (TB) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Diagnostics industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnosticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
According to APO Research, The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Includes
This report presents an overview of global market for Tuberculosis (TB) Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tuberculosis (TB) Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Tuberculosis (TB) Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tuberculosis (TB) Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis (TB) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tuberculosis (TB) Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
Tuberculosis (TB) Diagnostics segment by Company
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tuberculosis (TB) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Diagnostics industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnosticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Global Market Growth Prospects
1.5 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
1.5.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
1.5.3 Tuberculosis (TB) Diagnostics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET DYNAMICS
2.1 Tuberculosis (TB) Diagnostics Industry Trends
2.2 Tuberculosis (TB) Diagnostics Industry Drivers
2.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
2.4 Tuberculosis (TB) Diagnostics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Tuberculosis (TB) Diagnostics Key Company Head office and Area Served
3.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
3.5 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2023
3.6.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
4 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
4.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Tuberculosis (TB) Diagnostics Market Size by Type (2019-2030)
4.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Type (2019-2030)
5 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2019-2030)
5.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Danaher
6.1.1 Danaher Comapny Information
6.1.2 Danaher Business Overview
6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
6.1.5 Danaher Recent Developments
6.2 Roche
6.2.1 Roche Comapny Information
6.2.2 Roche Business Overview
6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
6.2.5 Roche Recent Developments
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Comapny Information
6.3.2 Thermo Fisher Scientific Business Overview
6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments
6.4 BD
6.4.1 BD Comapny Information
6.4.2 BD Business Overview
6.4.3 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
6.4.5 BD Recent Developments
6.5 Abbott
6.5.1 Abbott Comapny Information
6.5.2 Abbott Business Overview
6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
6.5.5 Abbott Recent Developments
6.6 Hologic
6.6.1 Hologic Comapny Information
6.6.2 Hologic Business Overview
6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
6.6.5 Hologic Recent Developments
6.7 Qiagen
6.7.1 Qiagen Comapny Information
6.7.2 Qiagen Business Overview
6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
6.7.5 Qiagen Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 Hain Lifescience
6.9.1 Hain Lifescience Comapny Information
6.9.2 Hain Lifescience Business Overview
6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
6.9.5 Hain Lifescience Recent Developments
6.10 Oxford Immunotec
6.10.1 Oxford Immunotec Comapny Information
6.10.2 Oxford Immunotec Business Overview
6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
6.10.5 Oxford Immunotec Recent Developments
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
7.2 North America Tuberculosis (TB) Diagnostics Market Size by Type
7.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
7.2.2 North America Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
7.2.3 North America Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
7.3 North America Tuberculosis (TB) Diagnostics Market Size by Application
7.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
7.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
7.3.3 North America Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country
7.4.1 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.4.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
7.4.4 North America Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2019-2030)
8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type
8.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
8.2.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
8.2.3 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application
8.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
8.3.2 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
8.3.3 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country
8.4.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.4.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
8.4.4 Europe Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Tuberculosis (TB) Diagnostics Market Size (2019-2030)
9.2 China Tuberculosis (TB) Diagnostics Market Size by Type
9.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
9.2.2 China Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
9.2.3 China Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
9.3 China Tuberculosis (TB) Diagnostics Market Size by Application
9.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
9.3.2 China Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
9.3.3 China Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Tuberculosis (TB) Diagnostics Market Size (2019-2030)
10.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type
10.2.1 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
10.2.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
10.2.3 Asia Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
10.3 Asia Tuberculosis (TB) Diagnostics Market Size by Application
10.3.1 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
10.3.2 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
10.3.3 Asia Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
10.4 Asia Tuberculosis (TB) Diagnostics Market Size by Country
10.4.1 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.4.3 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
10.4.4 Asia Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Tuberculosis (TB) Diagnostics Market Size (2019-2030)
11.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Type
11.2.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
11.2.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
11.2.3 MEALA Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
11.3 MEALA Tuberculosis (TB) Diagnostics Market Size by Application
11.3.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
11.3.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
11.3.3 MEALA Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
11.4 MEALA Tuberculosis (TB) Diagnostics Market Size by Country
11.4.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.4.3 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
11.4.4 MEALA Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Global Market Growth Prospects
1.5 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
1.5.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
1.5.3 Tuberculosis (TB) Diagnostics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET DYNAMICS
2.1 Tuberculosis (TB) Diagnostics Industry Trends
2.2 Tuberculosis (TB) Diagnostics Industry Drivers
2.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
2.4 Tuberculosis (TB) Diagnostics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Tuberculosis (TB) Diagnostics Key Company Head office and Area Served
3.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
3.5 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2023
3.6.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
4 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
4.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Tuberculosis (TB) Diagnostics Market Size by Type (2019-2030)
4.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Type (2019-2030)
5 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2019-2030)
5.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Danaher
6.1.1 Danaher Comapny Information
6.1.2 Danaher Business Overview
6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
6.1.5 Danaher Recent Developments
6.2 Roche
6.2.1 Roche Comapny Information
6.2.2 Roche Business Overview
6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
6.2.5 Roche Recent Developments
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Comapny Information
6.3.2 Thermo Fisher Scientific Business Overview
6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments
6.4 BD
6.4.1 BD Comapny Information
6.4.2 BD Business Overview
6.4.3 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
6.4.5 BD Recent Developments
6.5 Abbott
6.5.1 Abbott Comapny Information
6.5.2 Abbott Business Overview
6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
6.5.5 Abbott Recent Developments
6.6 Hologic
6.6.1 Hologic Comapny Information
6.6.2 Hologic Business Overview
6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
6.6.5 Hologic Recent Developments
6.7 Qiagen
6.7.1 Qiagen Comapny Information
6.7.2 Qiagen Business Overview
6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
6.7.5 Qiagen Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 Hain Lifescience
6.9.1 Hain Lifescience Comapny Information
6.9.2 Hain Lifescience Business Overview
6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
6.9.5 Hain Lifescience Recent Developments
6.10 Oxford Immunotec
6.10.1 Oxford Immunotec Comapny Information
6.10.2 Oxford Immunotec Business Overview
6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
6.10.5 Oxford Immunotec Recent Developments
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
7.2 North America Tuberculosis (TB) Diagnostics Market Size by Type
7.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
7.2.2 North America Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
7.2.3 North America Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
7.3 North America Tuberculosis (TB) Diagnostics Market Size by Application
7.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
7.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
7.3.3 North America Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country
7.4.1 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.4.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
7.4.4 North America Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2019-2030)
8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type
8.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
8.2.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
8.2.3 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application
8.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
8.3.2 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
8.3.3 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country
8.4.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.4.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
8.4.4 Europe Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Tuberculosis (TB) Diagnostics Market Size (2019-2030)
9.2 China Tuberculosis (TB) Diagnostics Market Size by Type
9.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
9.2.2 China Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
9.2.3 China Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
9.3 China Tuberculosis (TB) Diagnostics Market Size by Application
9.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
9.3.2 China Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
9.3.3 China Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Tuberculosis (TB) Diagnostics Market Size (2019-2030)
10.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type
10.2.1 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
10.2.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
10.2.3 Asia Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
10.3 Asia Tuberculosis (TB) Diagnostics Market Size by Application
10.3.1 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
10.3.2 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
10.3.3 Asia Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
10.4 Asia Tuberculosis (TB) Diagnostics Market Size by Country
10.4.1 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.4.3 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
10.4.4 Asia Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Tuberculosis (TB) Diagnostics Market Size (2019-2030)
11.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Type
11.2.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
11.2.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Type (2025-2030)
11.2.3 MEALA Tuberculosis (TB) Diagnostics Market Share by Type (2019-2030)
11.3 MEALA Tuberculosis (TB) Diagnostics Market Size by Application
11.3.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
11.3.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Application (2025-2030)
11.3.3 MEALA Tuberculosis (TB) Diagnostics Market Share by Application (2019-2030)
11.4 MEALA Tuberculosis (TB) Diagnostics Market Size by Country
11.4.1 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.4.3 MEALA Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
11.4.4 MEALA Tuberculosis (TB) Diagnostics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
